Immuneering (IMRX) Research & Development (2020 - 2026)
Immuneering (IMRX) recorded Research & Development of $14 million in Q2 2026, up 33.9% from $10.45 million a year earlier and up 31.5% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Immuneering's Research & Development came in at $44.76 million as of Jun 30, 2026, down 6.8% year-over-year; for FY2025, it was $42.05 million, down 12.3% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $47.96 million in FY2024 (+15.2%), $41.62 million in FY2023 (+14.8%), $36.27 million in FY2022 (+36.6%) and $26.54 million in FY2021 (+76.9%).
- The Q2 2026 figure is the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development rose in four of the last eight quarters, with growth averaging 2.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 68.0% in Q1 2022, against a decline of 37.7% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.65 million (Q1 2026), $9.25 million (Q4 2025) and $10.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Immuneering | 236.47 Mn | -470.52 Mn | - | 14.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 10.65 Mn |
| Dec 31, 2025 | 9.25 Mn |
| Sep 30, 2025 | 10.87 Mn |
| Jun 30, 2025 | 10.45 Mn |
| Mar 31, 2025 | 11.47 Mn |
| Dec 31, 2024 | 14.86 Mn |
| Sep 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | 10.65 Mn |
| Mar 31, 2024 | 11.20 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 10.05 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 10.21 Mn |
| Dec 31, 2022 | 9.87 Mn |
| Sep 30, 2022 | 9.36 Mn |
| Jun 30, 2022 | 7.98 Mn |
| Mar 31, 2022 | 9.06 Mn |
| Dec 31, 2021 | 7.95 Mn |
| Sep 30, 2021 | 6.21 Mn |
API Access
Immuneering Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();